Takeuchi Y - Search Results

1

Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity.

Del Rosario JMM, Smith M, Zaki K, Risley P, Temperton N, Engelhardt OG, Collins M, Takeuchi Y, Hufton SE. Del Rosario JMM, et al. Among authors: takeuchi y. Front Immunol. 2020 May 29;11:627. doi: 10.3389/fimmu.2020.00627. eCollection 2020. Front Immunol. 2020. PMID: 32547534 Free PMC article.

2

A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies.

Temperton NJ, Hoschler K, Major D, Nicolson C, Manvell R, Hien VM, Ha do Q, de Jong M, Zambon M, Takeuchi Y, Weiss RA. Temperton NJ, et al. Among authors: takeuchi y. Influenza Other Respir Viruses. 2007 May;1(3):105-12. doi: 10.1111/j.1750-2659.2007.00016.x. Influenza Other Respir Viruses. 2007. PMID: 19453415 Free PMC article.

3

Characterization of Antibody Interactions with the G Protein of Vesicular Stomatitis Virus Indiana Strain and Other Vesiculovirus G Proteins.

Munis AM, Tijani M, Hassall M, Mattiuzzo G, Collins MK, Takeuchi Y. Munis AM, et al. Among authors: takeuchi y. J Virol. 2018 Nov 12;92(23):e00900-18. doi: 10.1128/JVI.00900-18. Print 2018 Dec 1. J Virol. 2018. PMID: 30232190 Free PMC article.

4

Mass spectrometry analysis reveals differences in the host cell protein species found in pseudotyped lentiviral vectors.

Johnson S, Wheeler JX, Thorpe R, Collins M, Takeuchi Y, Zhao Y. Johnson S, et al. Among authors: takeuchi y. Biologicals. 2018 Mar;52:59-66. doi: 10.1016/j.biologicals.2017.12.005. Epub 2018 Feb 1. Biologicals. 2018. PMID: 29361371 Free PMC article.

5

Abrogation of Ref1 retrovirus restriction in human cells.

Towers G, Collins M, Takeuchi Y. Towers G, et al. Among authors: takeuchi y. J Virol. 2002 Mar;76(5):2548-50. doi: 10.1128/jvi.76.5.2548-2550.2002. J Virol. 2002. PMID: 11836433 Free PMC article.

6

Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes.

Temperton NJ, Chan PK, Simmons G, Zambon MC, Tedder RS, Takeuchi Y, Weiss RA. Temperton NJ, et al. Among authors: takeuchi y. Emerg Infect Dis. 2005 Mar;11(3):411-6. doi: 10.3201/eid1103.040906. Emerg Infect Dis. 2005. PMID: 15757556 Free PMC article.

7

Effect of the internal promoter on insertional gene activation by lentiviral vectors with an intact HIV long terminal repeat.

Knight S, Bokhoven M, Collins M, Takeuchi Y. Knight S, et al. Among authors: takeuchi y. J Virol. 2010 May;84(9):4856-9. doi: 10.1128/JVI.02476-09. Epub 2010 Feb 24. J Virol. 2010. PMID: 20181689 Free PMC article.

8

A lentiviral vector pseudotype suitable for vaccine development.

Lopes L, Dewannieux M, Takeuchi Y, Collins MK. Lopes L, et al. Among authors: takeuchi y. J Gene Med. 2011 Mar;13(3):181-7. doi: 10.1002/jgm.1553. J Gene Med. 2011. PMID: 21394858

9

Insertional mutagenesis by retroviral vectors: current concepts and methods of analysis.

Knight S, Collins M, Takeuchi Y. Knight S, et al. Among authors: takeuchi y. Curr Gene Ther. 2013 Jun 1;13(3):211-27. doi: 10.2174/1566523211313030006. Curr Gene Ther. 2013. PMID: 23590635 Review.

10

Use of Heterologous Vesiculovirus G Proteins Circumvents the Humoral Anti-envelope Immunity in Lentivector-Based In Vivo Gene Delivery.

Munis AM, Mattiuzzo G, Bentley EM, Collins MK, Eyles JE, Takeuchi Y. Munis AM, et al. Among authors: takeuchi y. Mol Ther Nucleic Acids. 2019 Sep 6;17:126-137. doi: 10.1016/j.omtn.2019.05.010. Epub 2019 May 28. Mol Ther Nucleic Acids. 2019. PMID: 31254925 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,134 results

Search Page

Filters